Morning Market Losers

shares dropped 24.76% to $5.64 after the company reported final analysis of Phase 2a ALS study.

shares dropped 13.23% to $4.33. Partner Communications reported the interest rate for the Series D Notes for the period commencing on December 31, 2014 and ending on March 30, 2015.

shares slipped 10.24% to $1.49 after the company issued an update regarding its outlook for the remainder of its fiscal year and announced the acquisition of Scribe Solutions.

fell 8.46% to $8.00. UBS downgraded Skilled Healthcare from Neutral to Sell and lowered the price target from $7.50 to $7.25.

shares declined 4.75% to $17.26. Crude oil futures fell 3.78% to trade at $50.70 a barrel.

shares dropped 1.94% to $156.79. Morgan Stanley downgraded Amgen from Overweight to Equalweight. Amgen and Kite Pharma announced a strategic cancer immunotherapy collaboration to advance the application of novel Chimeric Antigen Receptor (CAR) T cell therapies.

shares fell 1.23% to $80.44. Analysts at Janney Capital downgraded Starbucks from Buy to Neutral and lowered the price target from $90 to $85.